Boiron SA (BOI) - Financial and Strategic SWOT Analysis Review

Date: April 26, 2016
Pages: 36
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: BCE91DE6829EN
Leaflet:

Download PDF Leaflet

Boiron SA (BOI) - Financial and Strategic SWOT Analysis Review
Boiron SA (BOI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Boiron SA (Boiron) is a pharmaceutical company that develops, manufactures and commercializes homeopathic medicines. The company operates through two reportable business segments, namely, Non-proprietary homeopathic medicines, associated with precise therapeutic indications and dosage; and OTC specialties, no specific therapeutic indication or dosage. Its product portfolio comprises Camilia, Euphralia, Arnigel, Oscillococcinum, Sedatif PC, Homeoptic and Stodal. The company has operations in various countries across the world including France, Italy, Spain, Belgium, Switzerland, Germany, the Netherlands, Portugal, Czech Republic, Slovakia, Romania, Hungaria, Poland, Bulgaria, the US, Canada, Tunisia, Morocco, Russia and Brazil. It also manages five production facilities in France and Belgium. Boiron is headquartered in Sainte-Foy-les-Lyon, France.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

    Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

    Note: Some sections may be missing if data is unavailable for the company
  • SECTION 1 - ABOUT THE COMPANY

    Boiron SA - Key Facts
    Boiron SA - Key Employees
    Boiron SA - Key Employee Biographies
    Boiron SA - Major Products and Services
    Boiron SA - History
    Boiron SA - Company Statement
    Boiron SA - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries

    SECTION 2 – COMPANY ANALYSIS

    Boiron SA - Business Description
    Boiron SA - Corporate Strategy
    Boiron SA - SWOT Analysis
    SWOT Analysis - Overview
    Boiron SA - Strengths
    Strength - Research and Development Activities
    Strength - Operational Network
    Strength - Core Business: Non-proprietary homeopathic medicines Segment
    Boiron SA - Weaknesses
    Weakness - Higher Cost Structure
    Boiron SA - Opportunities
    Opportunity - Market Potential: Homeopathy
    Opportunity - Products in Pipeline
    Boiron SA - Threats
    Threat - Prejudice against Homeopathy
    Threat - Uncertain R&D Outcomes
    Threat - Growing Parallel Trade
    Boiron SA - Key Competitors

    SECTION 3 – COMPANY FINANCIAL RATIOS

    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts

    SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Boiron SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Boiron SA, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Boiron SA, Recent Deals Summary

    SECTION 5 – APPENDIX

    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Boiron SA, Key Facts
    Boiron SA, Key Employees
    Boiron SA, Key Employee Biographies
    Boiron SA, Major Products and Services
    Boiron SA, History
    Boiron SA, Subsidiaries
    Boiron SA, Key Competitors
    Boiron SA, Ratios based on current share price
    Boiron SA, Annual Ratios
    Boiron SA, Interim Ratios
    Boiron SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Boiron SA, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Boiron SA, Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios

    LIST OF FIGURES

    Boiron SA, Performance Chart (2011 - 2015)
    Boiron SA, Ratio Charts
    Boiron SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Boiron SA, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
    Skip to top


    Ask Your Question

    Boiron SA (BOI) - Financial and Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: